Te Li Chen
Chief Executive Officer at BIOGEND THERAPEUTICS CO., LTD.
Profile
Te Li Chen is currently the Chairman & General Manager at BioGend Therapeutics Co., Ltd.
and a Non-Executive Director at Jacobio Pharmaceuticals Group Co., Ltd.
He previously served as the Chairman at Mycenax Biotech, Inc. and as a Director at TPG Biologics, Inc. Prior to that, he was an Associate Professor at National Yang Ming University from 2006 to 2016.
Dr. Chen holds an undergraduate degree from National Defense Medical Center, conferred in 1995, and a doctorate degree from National Yang Ming University, conferred in 2008.
Te Li Chen active positions
| Companies | Position | Start |
|---|---|---|
| BIOGEND THERAPEUTICS CO., LTD. | Chief Executive Officer | 2016-07-06 |
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Director/Board Member | 2020-08-19 |
Former positions of Te Li Chen
| Companies | Position | End |
|---|---|---|
| National Yang Ming University | Corporate Officer/Principal | 2015-12-31 |
| TPG BIOLOGICS INC | Director/Board Member | - |
| MYCENAX BIOTECH INC. | Chairman | - |
Training of Te Li Chen
| National Yang Ming University | Doctorate Degree |
| National Defense Medical Center | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| MYCENAX BIOTECH INC. | Health Technology |
| BIOGEND THERAPEUTICS CO., LTD. | Commercial Services |
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Health Technology |
| Private companies | 1 |
|---|---|
TPG Biologics, Inc.
 TPG Biologics, Inc. Pharmaceuticals: MajorHealth Technology TPG Biologics, Inc. engages in the development of biopharmaceutical products. It offers antibody and protein drug design, cell line generation, process development, monoclonal antibody cell line similar drug products, and biological production for feasibility tests and animal studies. The company was founded on December 31, 2003 and headquartered in Taipei, Taiwan. | Health Technology |
- Stock Market
- Insiders
- Te Li Chen
